PLSE

NEUTRALAnalyst

Pulse Biosciences, Inc

2026-09-10

Price

$54.43

+11.56%

This is the 2026-09-10 snapshot — the signals and analysis for PLSE as of this single trading day.

View full PLSE research hub →

Score2.2Noise

Signals3/8 DNA0/13 Act · 2/4 Risk

SentimentNEUTRALScore: 9

Volume1.5xvs 20d avg

Analysis

Pulse Biosciences (PLSE) is demonstrating textbook High-Conviction Price Discovery, aggressively surging due to a fresh $73 Street price target and rising M&A speculation. Despite a macro backdrop plagued by 4.90% yields and geopolitical energy spikes, the stock's PERFECT_STACK signal and +82.0% relative strength confirm that institutional buyers are heavily absorbing any broader market weakness. In this resilient RISK_ON regime, capital is rotating into idiosyncratic, high-beta medical technology stories, further validated by recent open-market insider buying from the company's COO.

Fired Signals

GOLDEN CROSSMARKET LEADERPERFECT STACKWEAK FINISHEXTENSION

Key Takeaways

Actionable Thesis: PLSE is a structural long supported by disruptive nanosecond pulsed field ablation (nsPFA) technology, insider conviction, and a new $73 price target from Freedom Capital Markets.
Key Risk: As a clinical-stage bioelectric medicine company, PLSE remains highly sensitive to cost of capital; a sustained macro shock pushing the 10-year yield well above 4.90% could trigger multiple compression.
What to Watch: Price action around the immediate $58.90 52-week high for momentum continuation, and the $32.79 structural support level to protect against downside reversals.

← Back to 2026-09-10 View Full PLSE History →Yahoo Finance &nearr;